Page last updated: 2024-10-31

moxisylyte and Meniere Disease

moxisylyte has been researched along with Meniere Disease in 2 studies

Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)

Meniere Disease: A disease of the inner ear (LABYRINTH) that is characterized by fluctuating SENSORINEURAL HEARING LOSS; TINNITUS; episodic VERTIGO; and aural fullness. It is the most common form of endolymphatic hydrops.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Young, JR2

Other Studies

2 other studies available for moxisylyte and Meniere Disease

ArticleYear
Acetylator status and liver function profile changes in labyrinthine ischaemia patients treated with thymoxamine.
    The Journal of international medical research, 1980, Volume: 8, Issue:5

    Topics: Acetylation; Adult; Aged; Ear, Inner; Female; Humans; Ischemia; Liver Function Tests; Male; Meniere

1980
Retrospective assessment of thymoxamine (Opilon) in treatment of Ménières disease.
    The Journal of international medical research, 1978, Volume: 6, Issue:2

    Topics: Drug Evaluation; Female; Humans; Male; Meniere Disease; Moxisylyte; Retrospective Studies

1978